QUINAPRIL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Quinapril Hydrochloride, and what generic alternatives are available?
Quinapril Hydrochloride is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Lupin, Mylan, Prinston Inc, Sun Pharm Inds Ltd, Apotex, and Aurobindo Pharma. and is included in nineteen NDAs.
The generic ingredient in QUINAPRIL HYDROCHLORIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINAPRIL HYDROCHLORIDE?
- What are the global sales for QUINAPRIL HYDROCHLORIDE?
- What is Average Wholesale Price for QUINAPRIL HYDROCHLORIDE?
Summary for QUINAPRIL HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 19 |
Finished Product Suppliers / Packagers: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 27 |
Patent Applications: | 3,067 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in QUINAPRIL HYDROCHLORIDE? | QUINAPRIL HYDROCHLORIDE excipients list |
DailyMed Link: | QUINAPRIL HYDROCHLORIDE at DailyMed |
![QUINAPRIL HYDROCHLORIDE drug patent expirations Drug patent expirations by year for QUINAPRIL HYDROCHLORIDE](/p/graph/s/t/QUINAPRIL_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for QUINAPRIL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AHEPA University Hospital | Phase 4 |
University of Nebraska | Phase 4 |
Pfizer |
Pharmacology for QUINAPRIL HYDROCHLORIDE
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for QUINAPRIL HYDROCHLORIDE
US Patents and Regulatory Information for QUINAPRIL HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prinston Inc | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 205823-001 | Sep 15, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Lupin | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 077690-004 | Jun 20, 2006 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm Inds Ltd | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 076607-003 | Dec 15, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 076374-002 | Mar 31, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |